Alzheimer's Disease Trial, By Invitation
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have a confirmed diagnosis of Alzheimer's disease dementia, based on established international medical guidelines (the NIA-AA criteria).
- People whose dementia symptoms began before the age of 65.
- People aged between 50 and 75 years old (this applies to both the patient group and the healthy comparison group).
- People whose dementia is at a mild to moderate stage, based on a standard rating scale called the Clinical Dementia Rating (CDR), with a score between 0.5 and 2.
- People in the healthy comparison group who have normal thinking and memory abilities, shown by a memory test score of 24 or above (MMSE) and a CDR score of 0.
- People (and their family members) who are willing and able to give their agreement to take part in the trial.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have a confirmed diagnosis of epilepsy or a history of seizures.
- People who have had a significant brain or nervous system condition that has affected how the brain looks or works, such as a stroke, a head injury, or a brain tumour.
- People who have a significant or unstable medical condition affecting organs such as the kidneys, liver, lungs, heart, or metabolism.
- People who have misused or been dependent on alcohol or other substances in the past year, or who have a long history of substance misuse.
- People who are currently pregnant or breastfeeding.
- People who are unable to safely have an MRI, TMS, or PET scan — for example, those who have had brain aneurysm surgery, or who have a pacemaker, mechanical heart valves, a cochlear implant, or other metal devices in the body that are not safe to use in an MRI scanner.
- People who have had an allergic reaction to the scanning substances used in this trial (18F-florbetapir or 18F-FDG).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
Primary endpoints
Change from baseline MMSE total scores immediately after TBS intervention; Change from baseline MMSE total scores 4 weeks after TBS intervention; Change from baseline ADAS-Cog total scores immediately after TBS intervention; Change from baseline ADAS-Cog total scores 4 weeks after TBS intervention
Can't join this trial?
Data last synced from ClinicalTrials.gov: 18 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.